Table 1.
Key studies investigating the three most promising metabolic pathways
Study design | Study population | Specimen | Sample size | Findings | References |
---|---|---|---|---|---|
Cross-sectional (discovery and replication) | Human, British females | Serum | 598 | BCAA to histidine ratio | Zhai et al. [26] |
Cross-sectional (discovery and replication); longitudinal | Human, Canadian and Australian population | Plasma | 415 | BCAA to histidine ratio; lysoPC to PC ratio | Zhang et al. [27] |
Animal OA model | Sheep | Serum | 72 | BCAAs | Maher et al. [28] |
In vitro | Cultured human synovial tissue | OA synovium | 22 | Collagen, BCAA, energy and tryptophan metabolism | Adams et al. [48] |
Cross-sectional (discovery and replication) | Human, Canadian population | Plasma | 256 | Arginine | Zhang et al. [49] |
Cross-sectional | Human, Italian population | Plasma and SF | 63 | Arginine | Pascale et al. [51] |
Animal OA model | Rabbits | Plasma | 12 | Arginine | Ohnishi et al. [53] |
Cross-sectional | Human, German population | SF | 57 | PC metabolism | Kosinska et al. [54] |
Cross-sectional (discovery and replication) | Human, Canadian population | Plasma and SF | 227 | PC metabolism | Zhang et al. [55] |
Cross-sectional | Human, Dutch females | Plasma | 59 | LysoPC to PC ratio | Castro-Perez et al. [57] |
BCAA: branched chain amino acid; lysoPC: lysophosphatidylcholine; PC: phosphatidylcholine.